34:
157:
Dickenson has supervised more than 20 completed PhD students as well as contributing to undergraduate science and medical teaching. He is a founding and continuing member of the London Pain
Consortium, a Wellcome Trust Integrated Physiology Initiative, which funds a group of scientists in London and
153:
Tony
Dickenson was appointed to the Department of Pharmacology at University College in 1983. He conducted research into the mechanisms of pain and how pain can be controlled in both normal and patho-physiological conditions and how to translate basic science to the patient.
181:(DNIC). Tony's group was also the first to show the NMDA receptor mediation of wind-up and its role in persistent pain. Continuing work on central hyperexcitability has been seminal in understanding of pain in animals and humans.
161:
He has authored more than 330 refereed publications including
Science and Nature, edited three books and written many chapters. He has also been quoted in the media and in magazine articles as an expert on pain remediation.
174:, how neuronal systems alter in pathophysiological states and how novel and licensed drugs produce their effects with the aim of translating the basic research into clinical applications.
311:
39:
316:
106:
178:
306:
205:
197:
142:
102:
296:
170:
At UCL, the focus of his group's research has been based on understanding the transmission and control of
189:
65:
118:
301:
185:
193:
138:
92:
113:
201:
225:
258:
290:
158:
Oxford studying pain mechanisms and educating young scientists in this field.
33:
134:
75:
281:
200:, examining tissue specific deletion of targets and studies with
244:"The London Pain Consortium - Welcome to London Pain Consortium"
171:
243:
192:, investigating opioid pathways; collaborations with
112:
98:
88:
71:
61:
47:
21:
177:Early studies described the neuronal basis of
8:
18:
188:of the Department of Pharmacology at the
217:
107:National Institute for Medical Research
312:Academics of University College London
16:British professor of neuropharmacology
7:
184:Studies include collaborations with
317:Alumni of the University of Reading
179:Diffuse Noxious Inhibitory controls
14:
32:
282:http://dickensonlab.weebly.com
259:"dickenson ah - PubMed - NCBI"
1:
206:voltage-dependent Ca channels
198:Molecular Nociception Group
333:
143:University College, London
124:
103:University College London
81:
31:
208:in pathological states.
307:British neuroscientists
56:England, United Kingdom
52:Anthony Henry Dickenson
204:involving the role of
190:University of Arizona
66:University of Reading
202:Prof Annette Dolphin
186:Prof Frank Porreca
139:Neuropharmacology
131:Anthony Dickenson
128:
127:
119:Jean-Marie Besson
93:Neuropharmacology
83:Scientific career
26:Anthony Dickenson
324:
267:
266:
254:
248:
247:
240:
234:
233:
222:
137:is Professor of
114:Doctoral advisor
36:
19:
332:
331:
327:
326:
325:
323:
322:
321:
287:
286:
276:
271:
270:
256:
255:
251:
242:
241:
237:
224:
223:
219:
214:
168:
151:
105:
62:Alma mater
57:
54:
53:
43:
27:
24:
17:
12:
11:
5:
330:
328:
320:
319:
314:
309:
304:
299:
289:
288:
285:
284:
279:
275:
274:External links
272:
269:
268:
249:
235:
216:
215:
213:
210:
194:Prof John Wood
167:
164:
150:
147:
126:
125:
122:
121:
116:
110:
109:
100:
96:
95:
90:
86:
85:
79:
78:
73:
69:
68:
63:
59:
58:
55:
51:
49:
45:
44:
37:
29:
28:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
329:
318:
315:
313:
310:
308:
305:
303:
300:
298:
297:Living people
295:
294:
292:
283:
280:
278:
277:
273:
264:
260:
253:
250:
245:
239:
236:
231:
227:
221:
218:
211:
209:
207:
203:
199:
195:
191:
187:
182:
180:
175:
173:
165:
163:
159:
155:
148:
146:
144:
140:
136:
132:
123:
120:
117:
115:
111:
108:
104:
101:
97:
94:
91:
87:
84:
80:
77:
74:
70:
67:
64:
60:
50:
46:
41:
38:Dickenson at
35:
30:
20:
262:
252:
238:
229:
220:
183:
176:
169:
160:
156:
152:
130:
129:
99:Institutions
82:
302:1952 births
257:pubmeddev.
291:Categories
212:References
23:Professor
166:Research
263:nih.gov
230:Profile
196:of the
135:FMedSci
76:FMedSci
149:Career
89:Fields
72:Awards
226:"UCL"
172:pain
48:Born
42:2010
40:IASP
141:at
293::
261:.
228:.
145:.
133:,
265:.
246:.
232:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
